Archives

  • 2018-07
  • 2018-10
  • 2018-11
  • 2019-04
  • 2019-05
  • 2019-06
  • 2019-07
  • 2019-08
  • 2019-09
  • 2019-10
  • 2019-11
  • 2019-12
  • 2020-01
  • 2020-02
  • 2020-03
  • 2020-04
  • 2020-05
  • 2020-06
  • 2020-07
  • 2020-08
  • 2020-09
  • 2020-10
  • 2020-11
  • 2020-12
  • 2021-01
  • 2021-02
  • 2021-03
  • 2021-04
  • 2021-05
  • 2021-06
  • 2021-07
  • 2021-08
  • 2021-09
  • 2021-10
  • 2021-11
  • 2021-12
  • 2022-01
  • 2022-02
  • 2022-03
  • 2022-04
  • 2022-05
  • 2022-06
  • 2022-07
  • 2022-08
  • 2022-09
  • 2022-10
  • 2022-11
  • 2022-12
  • 2023-01
  • 2023-02
  • 2023-03
  • 2023-04
  • 2023-05
  • 2023-06
  • 2023-07
  • 2023-08
  • 2023-09
  • 2023-10
  • 2023-11
  • 2023-12
  • 2024-01
  • 2024-02
  • 2024-03
  • 2024-04
  • 2024-05
  • buy Z-YVAD-FMK br Bioinformatics analysis of the identified

    2018-11-03


    Bioinformatics analysis of the identified proteins To get a precise prediction, multiple bioinformatics methods were performed. First, the mouse buy Z-YVAD-FMK thus identified were associated with their putative human orthologs using NCBI׳s HomoloGene resource. Homogene annotations were downloaded from “ftp://ftp.ncbi.nih.gov/pub/HomoloGene/build67/homologene.data.” Then, the molecular functions of the all identified proteins were assigned on the basis of a search against the Human Protein Reference Database (HPRD, HPRD_Release9_041310.tar.gz). Results including biological process, cellular component, and molecular function were shown in Fig. 3B–D. Second, all the identified proteins were categorized functionally by GO analysis. GO was downloaded from the GeneOntology website (geneontology.org/ontology/ geneontology_edit.obo). Corresponding mouse GO-gene annotations were downloaded from the NCBI Entrez Gene ftp website (ftp://ftp.ncbi.nih.gov/gene/DATA/gene2go.gz). The GO analysis results, including the biological process (BP), cellular component (CC), and molecular function (MF), were generated. Gene set enrichment analysis revealed that all the differentially expressed proteins were enriched in 99 GO terms (p<0.05), including 58 BP, 23 MF and 18 CC. The top 10 GO terms ranked according to their significance level were listed in Fig. 4A. Third, gene-pathway annotations were compiled from Kyoto Encyclopedia of Genes and Genomes (KEGG), BioCarta (http://www.biocarta.com/), BioCyc, and Reactome. A hypergeometric test was chosen for statistical analysis, and significantly enriched pathways were identified at a corrected p-value of <0.05. Results were listed in Fig. 4B. Forth, protein–protein interaction networks were built using the Database of Interacting Proteins (DIP), Molecular Interaction (MINI), Database of Protein and Genetic Interaction (BioGRID), IntAct molecular interaction (IntAct), and STRING (http://string-db.org/) databases, and the data were imported into Cytoscape in order to visualize the graphs. The graphs was shown in Fig. 4C, and the details of top 10 proteins were listed in Table 3, including the degree, betweenness, gene ontology, and KEGG pathway.
    Verification of candidate proteins in clinical samples Lung squamous cell carcinoma specimens from 30 patients (11 lung squamous cell carcinoma and 19 adenocarcinoma) were chosen for IHC analysis. Histopathology reports were also obtained along with the samples, and shown in Table 4. Serum samples from 54 LC patients, 31 colorectal cancer patients, 31 esophageal cancer patients, and 84 normal individuals were used for the ELISA analysis. The clinical data of the LC patients are presented in Table 5.
    Data The data presented in this article show that mouse RAW 264.7 macrophages transfected with the pCMV5-StAR plasmid significantly increased (p<0.05) StAR protein expression when compared with mock-transfected (pCMV5) cells (Fig. 1A). Macrophages treated with increasing doses of either atRA or 9-cis RA (0–30µM), for 12h, enhanced cholesterol efflux to apolipoprotein A1 (Apo-A1; 20µg/ml) in a dose dependent manner, over untreated cells (Fig. 1B). Overexpression of StAR in RAW 264.7 macrophages resulted in 2–4 fold increases in cholesterol efflux to Apo-A1 in response to either atRA or 9-cis RA, over the responses seen in mock controls, suggesting StAR plays an important role in retinoid regulated cholesterol efflux in macrophases. Utilizing immunohistochemical staining, RAW 264.7 macrophages were found to express both StAR and ATP-binding cassette transporter A1 (ABCA1) proteins [1]. Macrophages treated without or with atRA (10µM) or atRA plus (Bu)2cAMP (0.1mM), for 12h, resulted increases in StAR and ABCA1 protein levels, over untreated cells. Treatment of atRA enhanced expression of both StAR and ABCA1 protein levels. Whereas (Bu)2cAMP had no apparent effects, it markedly increased both StAR and ABCA1 protein expression (data not shown; and Ref. [1]). These data are tightly associated with the research article published recently [1], and reinforce the importance of the StAR protein in retinoid mediated cholesterol efflux in mouse macrophages.